ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1

References

• Pinto Marques H, Gomes Da Silva S, De Martin E, et al. Emerging biomarkers in HCC patients: current status. Int J Surg. 2020;82S:70–76.
   PubMed Web of Science ®Google Scholar
• Guo M, Li N, Zheng J, et al. Epigenetic regulation of hepatocellular carcinoma progression through the mTOR signaling pathway. Can J Gastroenterol Hepatol. 2021;2021:5596712.
   PubMed Web of Science ®Google Scholar
• Couri T, Pillai A. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019;13(2):125–137.
   PubMed Web of Science ®Google Scholar
• Unfried JP, Sangro P, Prats-Mari L, et al. The landscape of lncRNAs in hepatocellular carcinoma: a translational perspective. Cancers (Basel). 2021;13(11). DOI:10.3390/cancers13112651.
   PubMed Web of Science ®Google Scholar
• Deng X, Bi Q, Chen S, et al. Identification of a five-autophagy-related-lncRNA signature as a novel prognostic biomarker for hepatocellular carcinoma. Front Mol Biosci. 2020;7:611626.
   PubMed Web of Science ®Google Scholar
• Zhao X, Bai Z, Li C, et al. Identification of a novel eight-lncRNA prognostic signature for HBV-HCC and analysis of their functions based on coexpression and ceRNA networks. Biomed Res Int. 2020;2020:8765461.
   PubMed Web of Science ®Google Scholar
• Guo C, Zhou S, Yi W, et al. Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma. Exp Mol Pathol. 2021;120:104638.
   PubMed Web of Science ®Google Scholar
• Li D, Zhang J, Li J. Role of miRNA sponges in hepatocellular carcinoma. Clin Chim Acta. 2020;500:10–19.
   PubMed Web of Science ®Google Scholar
• Dittmer J. The role of the transcription factor Ets1 in carcinoma. Semin Cancer Biol. 2015;35:20–38.
   PubMed Web of Science ®Google Scholar
• Rodgers JJ, McClure R, Epis MR, et al. ETS1 induces transforming growth factor beta signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells. J Cell Biochem. 2019;120(1):848–860.
   PubMed Web of Science ®Google Scholar
• Tomar S, Plotnik JP, Haley J, et al. ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase. Cancer Lett. 2018;414:190–204.
   PubMed Web of Science ®Google Scholar
• Kim GC, Kwon HK, Lee CG, et al. Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness. Oncogenesis. 2018;7(11):91.
   PubMedGoogle Scholar
• Hua S, Lei L, Deng L, et al. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene. 2018;37(12):1624–1636.
   PubMed Web of Science ®Google Scholar
• Ma N, Chen F, Shen SL, et al. MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1. Biochem Biophys Res Commun. 2015;461(4):618–623.
   PubMed Web of Science ®Google Scholar
• Shen X, Ding Y, Lu F, et al. Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis. Am J Transl Res. 2020;12(10):6381–6394.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhong Z, Tan HY, et al. Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR-22-3p. Clin Transl Med. 2020;10(6):e190.
   PubMed Web of Science ®Google Scholar
• Chen C, Huang Z, Mo X, et al. The circular RNA 001971/miR-29c-3p axis modulates colorectal cancer growth, metastasis, and angiogenesis through VEGFA. J Exp Clin Cancer Res. 2020;39(1):91.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang C, Zhao Y, et al. Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p/S100A4/p53 axis.Aging (Albany NY). 2019;11(24):12328–12344.
   PubMedGoogle Scholar
• Wu F, Wang F, Yang Q, et al. Upregulation of miRNA-23a-3p rescues high glucose-induced cell apoptosis and proliferation inhibition in cardiomyocytes. Vitro Cell Dev Biol Anim. 2020;56(10):866–877.
   PubMed Web of Science ®Google Scholar
• Zhang W, Mao S, Shi D, et al. MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1. Front Oncol. 2019;9:619.
   PubMed Web of Science ®Google Scholar
• Sun J, Xin K, Leng C, et al. Down-regulation of SNHG16 alleviates the acute lung injury in sepsis rats through miR-128-3p/HMGB3 axis. BMC Pulm Med. 2021;21(1):191.
   PubMed Web of Science ®Google Scholar
• Lei GL, Niu Y, Cheng SJ, et al. Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma. World J Gastroenterol. 2021;27(20):2586–2602.
   PubMed Web of Science ®Google Scholar
• Guo Z, Zhang J, Fan L, et al. Long noncoding RNA (lncRNA) small nucleolar RNA host gene 16 (SNHG16) predicts poor prognosis and sorafenib resistance in hepatocellular carcinoma. Med Sci Monit. 2019;25:2079–2086.
   PubMed Web of Science ®Google Scholar
• Mo W, Dai Y, Chen J, et al. Long noncoding RNA (lncRNA) MT1JP suppresses hepatocellular carcinoma (HCC) in vitro. Cancer Manag Res. 2020;12:7949–7960.
   PubMed Web of Science ®Google Scholar
• He J, Zuo Q, Hu B, et al. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Lett. 2019;450:98–109.
   PubMed Web of Science ®Google Scholar
• Bushweller JH. Targeting transcription factors in cancer - from undruggable to reality. Nat Rev Cancer. 2019;19(11):611–624.
   PubMed Web of Science ®Google Scholar
• Jiang M, Cheng Y, Wang D, et al. Transcriptional network modulated by the prognostic signature transcription factors and their long noncoding RNA partners in primary prostate cancer. EBioMedicine. 2021;63:103150.
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283.
   PubMed Web of Science ®Google Scholar
• Guo X, Zheng J, Yu MJ, et al. Long noncoding RNA SNHG3 promotes glioma tumorigenesis by sponging miR-485-5p to upregulate LMX1B expression. Kaohsiung J Med Sci. 2021. DOI:10.1002/kjm2.12411.
   Web of Science ®Google Scholar
• Li C, Dong B, Xu X, et al. LncRNA ARAP1-AS1 aggravates the malignant phenotypes of ovarian cancer cells through sponging miR-4735-3p to enhance PLAGL2 expression. Cytotechnology. 2021;73(3):363–372.
   PubMed Web of Science ®Google Scholar
• Yang X, Su W, Li Y, et al. MiR-22-3p suppresses cell growth via MET/STAT3 signaling in lung cancer. Am J Transl Res. 2021;13(3):1221–1232.
   PubMed Web of Science ®Google Scholar
• Lv KT, Liu Z, Feng J, et al. MiR-22-3p regulates cell proliferation and inhibits cell apoptosis through targeting the eIF4EBP3 gene in human cervical squamous carcinoma cells. Int J Med Sci. 2018;15(2):142–152.
   PubMed Web of Science ®Google Scholar
• Song W, Wenhui Z, Ruiqiang Y, et al. Long noncoding RNA PP7080 promotes hepatocellular carcinoma development by sponging mir-601 and targeting SIRT1. Bioengineered. 2021;12(1):1599–1610.
   PubMed Web of Science ®Google Scholar
• Zheng S, Guo Y, Dai L, et al. Long intergenic noncoding RNA01134 accelerates hepatocellular carcinoma progression by sponging microRNA-4784 and downregulating structure specific recognition protein 1. Bioengineered. 2020;11(1):1016–1026.
   PubMed Web of Science ®Google Scholar